First Solar (NASDAQ:FSLR) used its fourth-quarter and full-year 2025 earnings call to outline record shipment volumes, an expanding U.S. manufacturing footprint, and a 2026 outlook shaped by ongoing ...
Corcept Therapeutics (NASDAQ:CORT) reported higher revenue in 2025 and issued 2026 guidance as executives used the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results